Hostname: page-component-78c5997874-s2hrs Total loading time: 0 Render date: 2024-11-05T05:14:06.406Z Has data issue: false hasContentIssue false
  • English
  • Français

Early response to antidepressant treatment in bulimia nervosa

Published online by Cambridge University Press:  15 September 2009

R. Sysko ,
N. Sha ,
Y. Wang ,
N. Duan  and
B. T. Walsh
R. Sysko*
Affiliation:
Department of Psychiatry, College of Physicians and Surgeons of Columbia University, New York, NY, USA Division of Clinical Therapeutics, New York State Psychiatric Institute, New York, NY, USA
N. Sha
Affiliation:
Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY, USA
Y. Wang
Affiliation:
Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY, USA Division of Biostatistics and Data Coordination, New York State Psychiatric Institute, New York, NY, USA
N. Duan
Affiliation:
Department of Psychiatry, College of Physicians and Surgeons of Columbia University, New York, NY, USA Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY, USA Division of Biostatistics and Data Coordination, New York State Psychiatric Institute, New York, NY, USA
B. T. Walsh
Affiliation:
Department of Psychiatry, College of Physicians and Surgeons of Columbia University, New York, NY, USA Division of Clinical Therapeutics, New York State Psychiatric Institute, New York, NY, USA
*
*Address for correspondence: Dr R. Sysko, Columbia Center for Eating Disorders, New York State Psychiatric Institute, 1051 Riverside Drive, Unit 98, New York, NY 10032, USA. (Email: [email protected])
Get access Rights & Permissions [Opens in a new window]

Abstract

Background

Bulimia nervosa (BN) is a serious psychiatric disorder characterized by frequent episodes of binge eating and inappropriate compensatory behavior. Numerous trials have found that antidepressant medications are efficacious for the treatment of BN. Early response to antidepressant treatment, in the first few weeks after medication is initiated, may provide clinically useful information about an individual's likelihood of ultimately benefitting or not responding to such treatment. The purpose of this study was to examine the relationship between initial and later response to fluoxetine, the only antidepressant medication approved by the US Food and Drug Administration (FDA) for the treatment of BN, with the goal of developing guidelines to aid clinicians in deciding when to alter the course of treatment.

Method

Data from the two largest medication trials conducted in BN (n=785) were used. Receiver operating characteristic (ROC) curves were constructed to assess whether symptom change during the first several weeks of treatment was associated with eventual non-response to fluoxetine at the end of the trial.

Results

Eventual non-responders to fluoxetine could be reliably identified by the third week of treatment.

Conclusions

Patients with BN who fail to report a ⩾60% decrease in the frequency of binge eating or vomiting at week 3 are unlikely to respond to fluoxetine. As no reliable relationships between pretreatment characteristics and eventual response to pharmacotherapy have been identified for BN, early response is one of the only available indicators to guide clinical management.

Keywords

Antidepressant medicationbulimia nervosaearly responsefluoxetine
Type
Original Articles
Information
Psychological Medicine , Volume 40 , Issue 6 , June 2010 , pp. 999 - 1005
Copyright
Copyright © Cambridge University Press 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Agras, WS, Crow, SJ, Halmi, KA, Mitchell, JE, Wilson, GT, Kraemer, HC (2000). Outcome predictors for the cognitive behavior treatment of bulimia nervosa: data from a multisite study. American Journal of Psychiatry 157, 1302–1308.Google Scholar
APA (1987). Diagnostic and Statistical Manual of Mental Disorders, 3rd edn, text revision (DSM-IV-TR). American Psychiatric Association: Washington, DC.Google Scholar
APA (2000). Diagnostic and Statistical Manual of Mental Disorders, 4th edn, text revision (DSM-IV-TR). American Psychiatric Association: Washington, DC.Google Scholar
Becker, AE, Mickley, DW, Derenne, JL, Klibanski, A (2008). Eating disorders: evaluation and management. In Massachusetts General Hospital: Comprehensive Clinical Psychiatry (ed. Stern, T. A., Rosenbaum, J. F., Fava, M., Biederman, J. and Rauch, S. L.), pp. 499–518. Mosby, Inc: Philadelphia, PA.CrossRefGoogle Scholar
Fairburn, CG, Agras, WS, Walsh, BT, Wilson, GT, Stice, E (2004). Prediction of outcome in bulimia nervosa by early change in treatment. American Journal of Psychiatry 161, 2322–2324.Google Scholar
Fluoxetine Bulimia Nervosa Collaborative Study Group (1992). Fluoxetine in the treatment of bulimia nervosa: a multicenter, placebo-controlled, double-blind trial. Archives of General Psychiatry 49, 139–147.CrossRefGoogle Scholar
Goldstein, DJ, Wilson, MG, Thompson, VL, Potvin, JH, Rampey, AH (1995). Long-term fluoxetine treatment of bulimia nervosa. British Journal of Psychiatry 166, 660–666.Google Scholar
Grilo, CM, Masheb, RM (2007). Rapid response predicts binge eating and weight loss in binge eating disorder: findings from a controlled trial of orlistat with guided self-help cognitive behavioral therapy. Behaviour Research and Therapy 45, 2537–2550.Google Scholar
Grilo, CM, Masheb, RM, Wilson, GT (2006). Rapid response to treatment for binge eating disorder. Journal of Consulting and Clinical Psychology 74, 602–613.CrossRefGoogle ScholarPubMed
Hosmer, DW, Lemeshow, S (2000). Applied Logistic Regression, 2nd edn. Wiley: New York.CrossRefGoogle Scholar
Kaplan, AS, Walsh, BT, Olmsted, M, Attia, E, Carter, JC, Devlin, MJ, Pike, KM, Woodside, B, Rockert, W, Roberto, CA, Parides, M (2009). The slippery slope: prediction of successful weight maintenance in anorexia nervosa. Psychological Medicine 10, 1–9.Google Scholar
Kinon, BJ, Chen, L, Ascher-Svanum, H, Stauffer, VL, Kollack-Walker, S, Sniadecki, JL, Kane, JM (2008). Predicting response to atypical antipsychotics based on early response in the treatment of schizophrenia. Schizophrenia Research 102, 230–240.Google Scholar
le Grange, D, Doyle, P, Crosby, RD, Chen, E (2008). Early response to treatment in adolescent bulimia nervosa. International Journal of Eating Disorders 41, 755–757.Google Scholar
Masheb, RM, Grilo, CM (2007). Rapid response predicts treatment outcomes in binge eating disorder: implications for stepped care. Journal of Consulting and Clinical Psychology 75, 639–644.Google Scholar
McFall, RM, Treat, TA (1999). Quantifying the information value of clinical assessments with signal detection theory. Annual Review of Psychology 50, 215–241.CrossRefGoogle ScholarPubMed
NICE (2004). Eating Disorders: Core Interventions in the Treatment and Management of Eating Disorders in Primary and Secondary Care. National Institute for Clinical Excellence: London.Google Scholar
Obuchowski, NA (2006). An ROC-type measure of diagnostic accuracy when the gold standard is continuous-scale. Statistical Medicine 25, 481–493.Google Scholar
Pollack, MH, Kornstein, SG, Spann, ME, Crits-Christoph, P, Raskin, J, Russell, JM (2008). Early improvement during duloxetine treatment of generalized anxiety disorder predicts response and remission at endpoint. Journal of Psychiatric Research 42, 1176–1184.Google Scholar
Pope, HG, Hudson, JI, Jonas, JM, Yurgelun-Todd, D (1983). Bulimia treated with imipramine: a placebo-controlled, double-blind study. American Journal of Psychiatry 140, 554–558.Google Scholar
Sadock, BJ, Alcott Sadock, V (2007). Kaplan and Sadock's Synopsis of Psychiatry: Behavioral Sciences/Clinical Psychiatry, 10th edn. Lippincott Williams & Wilkins: Philadelphia, PA.Google Scholar
Shapiro, JR, Berkman, ND, Brownley, KA, Sedway, JA, Lohr, KN, Bulik, CM (2007). Bulimia nervosa treatment: a systematic review of randomized controlled trials. International Journal of Eating Disorders 40, 321–336.Google Scholar
Szegedi, A, Jansen, WT, van Willigenburg, AP, van der Meulen, E, Stassen, HH, Thase, ME (2009). Early improvement in the first 2 weeks as a predictor of treatment outcome in patients with major depressive disorder: a meta-analysis including 6562 patients. Journal of Clinical Psychiatry 70, 344–353.Google Scholar
Tao, R, Emslie, G, Mayes, T, Nakonezny, P, Kennard, B, Hughes, C (2009). Early prediction of acute antidepressant treatment response and remission in pediatric major depressive disorder. Journal of the American Academy of Child and Adolescent Psychiatry 48, 71–78.Google Scholar
Walsh, BT (2008). Eating disorders. In Psychiatry, 3rd edn (ed. Tasman, A., Kay, J., Lieberman, J. A., First, M. B. and Maj, M.), pp. 1609–1625. John Wiley & Sons, Ltd.: West Sussex, UK.Google Scholar
Walsh, BT, Sysko, R, Parides, MK (2006). Early response to medication among women with bulimia nervosa. International Journal of Eating Disorders 39, 72–75.CrossRefGoogle ScholarPubMed
Walsh, BT, Wilson, GT, Loeb, KL, Devlin, MJ, Pike, KM, Roose, SP, Fleiss, J, Waternaux, C (1987). Medication and psychotherapy in the treatment of bulimia nervosa. American Journal of Psychiatry 154, 523–531.Google Scholar
Wilson, GT, Fairburn, CG (2007). Treatments for eating disorders. In Treatments that Work, 3rd edn (ed. Nathan, P. E. and Gorman, J. M.), pp. 579–610. Oxford University Press: New York.Google Scholar
Wilson, GT, Fairburn, CG, Agras, WS, Walsh, BT, Kraemer, H (2002). Cognitive-behavioral therapy for bulimia nervosa: time course and mechanisms of change. Journal of Consulting and Clinical Psychology 70, 267–274.Google Scholar
Wilson, GT, Loeb, KL, Walsh, BT, Labouvie, E, Petkova, E, Liu, X, Waternaux, C (1999). Psychological versus pharmacological treatments of bulimia nervosa: predictors and processes of change. Journal of Consulting and Clinical Psychology 67, 451–459.CrossRefGoogle ScholarPubMed
Zhu, AJ, Walsh, BT (2002). Pharmacologic treatment of eating disorders. Canadian Journal of Psychiatry 47, 227–234.CrossRefGoogle ScholarPubMed